Akcea, Ionis report positive phase 2 study results of AKCEA-ANGPTL3-LRx MD bureau2 Feb 2020 10:30 AM ISTBoston: Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. recently announced...